Search Results - "Martin Huertas, R."

Benefit of immunotherapy (IT) in advanced non-small cell lung cancer (NSCLC) in elderly patients (EP) by Corral de la Fuente, E., Barquín García, A., Saavedra Serrano, C., Olmedo García, M.E., Martin Huertas, R., Serrano Domingo, J.J., Albarrán Artahona, V., Gómez Rueda, A.

Get full text

Efficacy of trastuzumab-emtansina (T-DM1) in HER2-positive breast cancer (BC) with brain metastases (BM): A single institution experience by Martin Huertas, R., Lopez Miranda, E., Corral de la Fuente, E., Serrano Domingo, J.J., Fernandez Abad, M., Martinez, N., Guerra, E.M., Cortes Salgado, A., Gion Cortes, M., Carrato Mena, A.

Get full text

Association of immune-related adverse events (irAEs) and immunotherapy (IT) benefit in advanced non-small cell lung cancer (NSCLC) by Saavedra Serrano, C., Barquín García, A., Corral de la Fuente, E., Serrano Domingo, J.J., Albarrán Artahona, V., Martin Huertas, R., Gómez Rueda, A., Olmedo García, M.E.

Get full text

Exploratory analysis of clinical benefit of ipilimumab and nivolumab treatment in patients with metastatic melanoma from a single institution by Vila, C. M., Moreno, F. A., Estébanez, M. M., Ares, G. R., Villacampa, G., Dashti, P., Oberoi, H. S., Martin-Huertas, R., Jares, P., Alos, L., Teixido, C., Rull, R., Sanchez, M., Malvehy, J., Carcelero, E., Valduvieco, I., Fernandez, A. A.

“…Purpose We retrospectively analysed overall survival (OS) and potential predictive biomarkers of OS in patients with metastatic melanoma treated with…”
Get full text

Locally advanced unresectable or metastatic pancreatic adenocarcinoma in patients under 65 years with good performance status (PS) at Ramón y Cajal University Hospital in Madrid by Martín Huertas, R., Longo Muñoz, F., Serrano Domingo, J., Corral de la Fuente, E., Pachón Olmos, V., Rodriguez Garrote, M., Fuentes, R., Ferreiro Monteagudo, R., Vaz, M., Carrato, A.

Get full text

FOLFIRINOX versus Nab-paclitaxel plus gemcitabine in the first-line chemotherapy for patients with advanced pancreatic ductal adenocarcinoma: a multivariate analysis of prognostic factors in a national cohort (Comunica-TTD working group) by Longo Muñoz, F., Castillo Trujillo, O., Serrano Domingo, J., Martín Huertas, R., Corral de la Fuente, E., San Juan, A., Portela, J., Cano, J., Reguera Puertas, P., Rodriguez Garrote, M., Izquierdo Manuel, M., Jimenez Fonseca, P., Carrato, A., Aranda, E.

Get full text

Impact on survival of local complications in Pancreatic Cancer: experience at the Ramón y Cajal University Hospital (HURyC) by Serrano Domingo, J., Martín Huertas, R., Corral de la Fuente, E., Barquín García, A., Saavedra Serrano, C., Albarrán Artahona, V., Reguera Puertas, P., Fuentes, R., Ferreiro Monteagudo, R., Olmos, V. Pachón, Vaz, M., Villamayor Delgado, M., Rodriguez Garrote, M., Carrato, A., Longo Muñoz, F.

Get full text

Efficacy of adjuvant chemotherapy for elderly patients with colon cancer by Delgado, M. Villamayor, Serrano, C. Saavedra, de la Fuente, E. Corral, García, A. Barquín, Saez, O. Martínez, Huertas, R. Martín, Domingo, J. Serrano, Cerrillo, J. Molina, Muñoz, F. Longo, Olmos, V. Pachón, Garrote, M. Rodriguez, Puertas, P. Reguera, Vaz, M., Carrato, A., Monteagudo, R. Ferreiro

Get full text

Analysis of the benefit of the adjuvant chemotherapy in stage II colon cancer according to the presence of classic poor risk factors: Our experience in Ramon y Cajal Hospital by Serrano, C. Saavedra, Delgado, M. Villamayor, de la Fuente, E. Corral, García, A. Barquín, Domingo, J. Serrano, Huertas, R. Martín, Saez, O. Martínez, Muñoz, F. Longo, Puertas, P. Reguera, Olmos, V. Pachón, Garrote, M. Rodriguez, Vaz, M., Fuentes, R., Carrato, A., Monteagudo, R Ferreiro

Get full text

Benefit of the addition of oxaliplatin to 5-FU/leucovorin or capecitabine in adjuvant therapy for stage II/III colorectal cancer in elderly patients: Experience in Ramon y Cajal University Hospital by de la Fuente, E. Corral, Serrano, C. Saavedra, Delgado, M. Villamayor, García, A. Barquín, Huertas, R. Martín, Domingo, J. Serrano, Saez, O. Martínez, Olmos, V. Pachón, Garrote, M. Rodriguez, Muñoz, F. Longo, Puertas, P. Reguera, Guillén-Ponce, C., Carrato, A., Monteagudo, R. Ferreiro

Get full text

Impact of adding oxaliplatin to fluoropyrimidines in the adjuvant therapy in stage II in colon cancer: Experience in Ramon y Cajal Universitary Hospital by Huertas, R. Martín, Domingo, J. Serrano, de la Fuente, E. Corral, García, A. Barquín, Delgado, M. Villamayor, Serrano, C. Saavedra, Saez, O. Martínez, Muñoz, F. Longo, Olmos, V. Pachón, Garrote, M. Rodriguez, Vaz, M., Carrato, A., Puertas, P. Reguera, Fuentes, R., Monteagudo, R. Ferreiro

Get full text

Analysis of global factors associated with survival in esophageal squamous cell carcinoma: Our experience at Ramon y Cajal Hospital by García, A. Barquín, Domingo, J. Serrano, Serrano, C. Saavedra, Artahona, V. Albarrán, Delgado, M. Villamayor, Saez, O. Martínez, Cerrillo, J. Molina, Huertas, R. Martín, de la Fuente, E. Corral, Monteagudo, R. Ferreiro, Garrote, M. Rodriguez, Olmos, V. Pachón, Vaz, M., Puertas, P. Reguera, Guillén-Ponce, C., Carrato, A., Muñoz, F. Longo

Get full text

Analysis of classical high risk factors in stage III colon cancer: Experience at University Hospital Ramon y Cajal (UHRyC) by Domingo, J. Serrano, Huertas, R. Martín, García, A. Barquín, de la Fuente, E. Corral, Serrano, C. Saavedra, Delgado, M. Villamayor, Saez, O. Martínez, Muñoz, F. Longo, Olmos, V Pachón, Garrote, M. Rodriguez, Vaz, M., Puertas, P Reguera, Fuentes, R., Carrato, A., Monteagudo, R. Ferreiro

Get full text

Predictive factors for early relapse and survival in resected pancreatic cancer: A single institution experience by Serrano, C. Saavedra, Puertas, P. Reguera, Saez, O. Martínez, Muñoz, F. Longo, García, A. Barquín, Artahona, V. Albarrán, Delgado, M. Villamayor, Cerrillo, J. Molina, de la Fuente, E. Corral, Huertas, R. Martín, Domingo, J. Serrano, Olmos, V. Pachón, Monteagudo, R. Ferreiro, Garrote, M. Rodriguez, Vaz, M., Fuentes, R., Guillén-Ponce, C., Carrato, A.

Get full text

169P_PRBenefit of immunotherapy (IT) in advanced non-small cell lung cancer (NSCLC) in elderly patients (EP) by Corral de la Fuente, E, Barquín García, A, Saavedra Serrano, C, Olmedo García, M E, Martin Huertas, R, Serrano Domingo, J J, Albarrán Artahona, V, Gómez Rueda, A

Get full text

155PAssociation of immune-related adverse events (irAEs) and immunotherapy (IT) benefit in advanced non-small cell lung cancer (NSCLC) by Saavedra Serrano, C, Barquín García, A, Corral de la Fuente, E, Serrano Domingo, J J, Albarrán Artahona, V, Martin Huertas, R, Gómez Rueda, A, Olmedo García, M E

Get full text

1744P COVID-19 in cancer patients: Risk factors for the development of severe clinical event (SCE) by Serrano Domingo, J.J., Corral de la Fuente, E., Martin Huertas, R., Vida Navas, E.M., Soto Castillo, J.J., Sanz Gomez, L., Torres Jimenez, J., Esteban Villarrubia, J., Orejana Martin, I., Alvarez Ballesteros, P., Pozas Perez, J., San Roman Gil, M.V., Garrido Lopez, P., Carrato Mena, A.

Get full text

188PEfficacy of trastuzumab-emtansina (T-DM1) in HER2-positive breast cancer (BC) with brain metastases (BM): A single institution experience by Martin Huertas, R, Lopez Miranda, E, Corral de la Fuente, E, Serrano Domingo, J J, Fernandez Abad, M, Martinez, N, Guerra, E M, Cortes Salgado, A, Gion Cortes, M, Carrato Mena, A

Get full text

Cardiac toxicity of immune-checkpoint inhibitors: a clinical case of nivolumab-induced myocarditis and review of the evidence and new challenges by Martin Huertas, Roberto, Saavedra Serrano, Cristina, Perna, Cristian, Ferrer Gómez, Ana, Alonso Gordoa, Teresa

“…Immune checkpoint inhibitors have revolutionized cancer treatment due to their undeniable efficacy, but a range of new adverse events (AE) has emerged. In…”
Get full text

P-335FOLFIRINOX versus Nab-paclitaxel plus gemcitabine in the first-line chemotherapy for patients with advanced pancreatic ductal adenocarcinoma: a multivariate analysis of prognostic factors in a national cohort (Comunica-TTD working group) by Longo Muñoz, F, Castillo Trujillo, O, Serrano Domingo, J, Martín Huertas, R, Corral de la Fuente, E, San Juan, A, Portela, J, Cano, J, Reguera Puertas, P, Rodriguez Garrote, M, Izquierdo Manuel, M, Jimenez Fonseca, P, Carrato, A, Aranda, E

Get full text